[ (1Hindol5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenrative disorders.

Details for Australian Patent Application No. 2006326258 (hide)

Owner Novartis AG

Inventors Feuerbach, Dominik; Frederiksen, Mathias; Wagner, Beatrix; Roy, Bernard Lucien; Hurth, Konstanze

Agent Davies Collison Cave

Pub. Number AU-B-2006326258

PCT Pub. Number WO2007/068476

Priority 0525672.2 16.12.05 GB

Filing date 14 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 9 June 2011

International Classifications

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/068476 Priority application(s): WO2007/068476

9 June 2011 Application Accepted

  Published as AU-B-2006326258

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326264-Packaged concentrate for preparing a bouillon, soup, sauce, gravy or for use as a seasoning, the concentrate comprising xanthan and locust bean gum

2006326257-(1-aza-bicyclo[3.3.1] non4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amin es as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders